Science & Technology
Science and Technology
Science and Technology
Mon, March 23, 2009
Sun, March 22, 2009
Fri, March 20, 2009 CDEX Inc.: CDEX ID2 Meth Scanner(TM) Sold by Decatur Electronics Assists Law Enforcement in Methamphetamine Busts
TUCSON, AZ--(Marketwire - March 20, 2009) - CDEX Inc. (
"Since debuting at the October 2008 COPS West Tradeshow, the ID2 Meth Scanner has been involved with a growing number of law enforcement busts," said Tim Shriver, Jr., CDEX Security Division Sales Manager. "The most recent involved a traffic stop where the driver had two bags of white substance, only one of which the Meth Scanner identified as methamphetamine. Upon further analysis, the Scanner had correctly identified the meth and correctly rejected the second bag which was a cutting agent to be used in conjunction with sale of the meth. This is typical of the reports that we are receiving regarding this initial phase of Meth Scanner use by police in the field. We are excited by the results and the growing interest in the ID2 Meth Scanner."
For more information regarding the ID2 Meth Scanner, please visit [ http://www.decaturradar.com/decatur/news_profile.php?id=55 ].
About CDEX
CDEX develops, manufactures and globally distributes products to the healthcare and security markets. The ValiMed™ product line provides life-saving validation of high-risk medications and returned narcotics. The ID2™ product line detects trace amounts or illegal drugs, such as methamphetamine. CDEX expects to advance its patented technologies to serve additional markets. To meet its plans, CDEX must strengthen its financial position as stated periodically in its SEC filings. For more information, visit [ www.cdexinc.com ].
Non-historical statements are forward-looking, as defined in federal securities laws, and generally can be identified by words such as "expects," "plans, " "may," "believes," "should," "intends," and similar words. These statements pose risks and uncertainties that cannot be accurately predicted or quantified and, consequently, actual results may differ materially from those expressed or implied. Such risks and uncertainties include, without limitation, the effectiveness, profitability and marketability of products, the protection of intellectual property and proprietary information, and other risks detailed periodically in filings with the SEC. There is no obligation to update any forward-looking statements.
